Today: 29 June 2026
Fannie Mae stock (FNMA) slides 4% into year-end as housing data and Fed minutes loom
30 December 2025
1 min read

Fannie Mae stock (FNMA) slides 4% into year-end as housing data and Fed minutes loom

NEW YORK, December 30, 2025, 01:40 ET — Market closed

  • Fannie Mae’s FNMA shares closed down 4.1% on Monday, underperforming peer Freddie Mac.
  • U.S. pending home sales jumped to the highest level in nearly three years, helped by improved affordability, NAR said.
  • Traders are watching Tuesday home-price readings and Wednesday’s Fed minutes for fresh rate signals.

Fannie Mae shares sank on Monday, closing down 4.1% at $10.33 in over-the-counter trading, after touching $10.55 at the high and $10.08 at the low. Volume was about 3.0 million shares.

The stock’s swings matter because Fannie Mae sits at the center of the U.S. mortgage machine. It buys home loans from lenders and guarantees mortgage-backed securities, so investor focus tends to snap to mortgage rates and the health of housing demand.

With the year ending, that focus is sharpening. Fresh housing-price data and the Federal Reserve’s latest meeting minutes are due in the next two sessions, giving markets new inputs on affordability and the outlook for rates.

Freddie Mac’s common stock (FMCC) also fell on Monday, down 2.8% to $9.83, pointing to a broader move across the two U.S. housing-finance peers.

The slide came as U.S. equities finished lower on Monday in thin holiday trading, leaving investors sensitive to macro headlines rather than company-specific developments.

On the housing front, contracts to buy previously owned U.S. homes rose 3.3% in November to the highest level since February 2023, the National Association of Realtors said. “Homebuyer momentum is building,” said Lawrence Yun, the NAR’s chief economist. Reuters

Pending home sales track signed contracts and typically lead closed sales by a month or two. Stronger contract activity can signal firmer mortgage demand, but investors still watch whether the pickup sticks as financing costs fluctuate.

Rates remain the hinge. Lower mortgage rates tend to lift affordability and turnover, which can increase the flow of loans through the housing-finance system — but abrupt shifts in rate expectations can move mortgage-linked assets quickly.

Before the next session, attention turns to Tuesday’s U.S. data calendar, including the S&P Case-Shiller 20-city home price index for October and Chicago PMI for December.

The Federal Housing Finance Agency is also scheduled to publish its next monthly House Price Index report on Tuesday, another read on home-price momentum as 2025 closes out.

On Wednesday, the Fed is slated to release minutes from its most recent policy meeting — the detailed record of the discussion — a potential catalyst for Treasury yields and, by extension, mortgage-rate expectations.

Technically, traders will eye whether FNMA can hold above the $10 area after Monday’s $10.08 intraday low, with resistance near the prior close around $10.77. For a market where liquidity is thinner than on major exchanges, breaks of round levels can amplify short-term moves.

Fannie Mae last reported quarterly results in late October, and investors are likely to watch for any update on the timing of its next financial report as the calendar turns.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Singular Health Group Applies for Quotation of Additional ASX Shares
    June 28, 2026, 8:02 PM EDT. Singular Health Group Ltd has applied for the quotation of 2,571,222 new ordinary fully paid shares on the Australian Securities Exchange (ASX). This move aims to expand the company's market presence and increase liquidity. The application signifies the firm's intent to raise capital or satisfy existing commitments through share issuance. Investors will monitor the impact on share supply and potential dilution. The announcement reflects Singular Health's ongoing efforts to support its growth and operational strategies.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Previous Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop